Seite - (000009) - in Advances in Neuroimmunology

ix 2. Cui, C.; Shurtleff, D.; Harris, R.A. Neuroimmune mechanisms of alcohol and drug addiction. Int. Rev. Neurobiol. 2014, 118, 1–12. 3. Erickson, M.A.; Dohi, K.; Banks, W.A. Neuroinflammation: A common pathway in cns diseases as mediated at the blood-brain barrier. Neuroimmunomodulation 2012, 19, 121–130. 4. Shie, F.S.; Chen, Y.H.; Chen, C.H.; Ho, I.K. Neuroimmune pharmacology of neurodegenerative and mental diseases. J. Neuroimmune Pharmacol. 2011, 6, 28–40. 5. Crews, F.T.; Lawrimore, C.J.; Walter, T.J.; Coleman, L.G., Jr. The role of neuroimmune signaling in alcoholism. Neuropharmacology 2017, 122, 56–73. 6. Northrop, N.A.; Yamamoto, B.K. Neuroimmune pharmacology from a neuroscience perspective. J. Neuroimmune Pharmacol. 2011, 6, 10–19. 7. Gruol, D.L. Impact of increased astrocyte expression of IL-6, CCL2 or CXCL10 in transgenic mice on hippocampal synaptic function. Brain Sci. 2016, 6. 8. Erta, M.; Giralt, M.; Jimenez, S.; Molinero, A.; Comes, G.; Hidalgo, J. Astrocytic il-6 influences the clinical symptoms of eae in mice. Brain Sci. 2016, 6. 9. Mukandala, G.; Tynan, R.; Lanigan, S.; O’Connor, J.J. The effects of hypoxia and inflammation on synaptic signaling in the cns. Brain Sci. 2016, 6. 10. Mori, S.; Maher, P.; Conti, B. Neuroimmunology of the interleukins 13 and 4. Brain Sci. 2016, 6. 11. Grimmig, B.; Morganti, J.; Nash, K.; Bickford, P.C. Immunomodulators as therapeutic agents in mitigating the progression of parkinson's disease. Brain Sci. 2016, 6. 12. Lacagnina, M.J.; Rivera, P.D.; Bilbo, S.D. Glial and neuroimmune mechanisms as critical modulators of drug use and abuse. Neuropsychopharmacology 2017, 42, 156–177. 13. Montesinos, J.; Alfonso-Loeches, S.; Guerri, C. Impact of the innate immune response in the actions of ethanol on the central nervous system. Alcohol. Clin. Exp. Res. 2016, 40, 2260–2270. 14. Gonzalez, H.; Elgueta, D.; Montoya, A.; Pacheco, R. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases. J. Neuroimmunol. 2014, 274, 1–13. 15. Marshall, S.A.; Geil, C.R.; Nixon, K. Prior binge ethanol exposure potentiates the microglial response in a model of alcohol-induced neurodegeneration. Brain Sci. 2016, 6. 16. Knapp, D.J.; Harper, K.M.; Whitman, B.A.; Zimomra, Z.; Breese, G.R. Stress and withdrawal from chronic ethanol induce selective changes in neuroimmune mrnas in differing brain sites. Brain Sci. 2016, 6. 17. Chang, S.L.; Huang, W.; Mao, X.; Sarkar, S. Nlrp12 inflammasome expression in the rat brain in response to lps during morphine tolerance. Brain Sci. 2017, 7. 18. Sharma, D.; Kanneganti, T.D. The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation. J. Cell Biol. 2016, 213, 617–629. 19. Liu, H.; Xu, E.; Liu, J.; Xiong, H. Oligodendrocyte injury and pathogenesis of HIV-1-associated neurocognitive disorders. Brain Sci. 2016, 6. 20. Zeis, T.; Enz, L.; Schaeren-Wiemers, N. The immunomodulatory oligodendrocyte. Brain Res. 2016, 1641, 139–148. 21. Nizamutdinov, D.; Shapiro, L.A. Overview of traumatic brain injury: An immunological context. Brain Sci. 2017, 7.